Urinary Prostaglandin F2α Is Generated from the Isoprostane Pathway and Not the Cyclooxygenase in Humans
Open accessThe DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
Abstract
Prostaglandins (PGs) derived from the enzymatic oxidation of arachidonic acid by the cyclooxygenases (COXs) are potent lipid mediators involved in human physiology and pathophysiology. Structurally similar compounds, the isoprostanes (IsoPs), are generated from the free radical-catalyzed oxidation of arachidonic acid independent of COX. IsoPs exhibit significant bioactivity and play a role in the pathogenesis of diseases associated with oxidant injury. As one of the major PGs, prostaglandin F(2alpha) (PGF(2alpha)) is present in human urine in significant concentrations and is presumed to be derived from COX activity. We determined, however, that levels of putative PGF(2alpha) in urine cannot be suppressed by nonsteroidal anti-inflammatory agents, suggesting that it is generated via another mechanism(s). An important difference between COX-derived PGF(2alpha) and the IsoPs is that the former is an optically pure compound, whereas IsoPs are racemic. Utilizing a rodent model of oxidative stress, we now show that significant amounts of compounds identical in all respects to PGF(2alpha) and its enantiomer, ent-PGF(2alpha), are formed in equal amounts esterified in tissue phospholipids, suggesting that these compounds are derived via the IsoP pathway. Further, employing liquid chromatography/mass spectrometry, the vast majority of putative PGF(2alpha) in human urine is derived from the free radical-initiated peroxidation of arachidonate independent of COX and is composed of PGF(2alpha) and its enantiomer, although the latter compound is approximately 2-fold more abundant. Thus, quantification of urinary PGF(2alpha) actually reflects oxidative stress status as opposed to COX activity. Indeed, levels of this compound are elevated in urine from cigarette smokers and in humans with hypercholesterolemia, two conditions associated with oxidant stress. The elucidation that urinary PGF(2alpha) in humans is derived from the IsoP pathway has implications regarding PG formation and inhibition in vivo.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures






Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The existence of spaceflight-induced mitochondrial stress is further supported by metabolite studies reporting increased urinary 8-OHdG and prostaglandin F2 alpha.”
From Comprehensive Multi-omics Analysis Reveals Mitochondrial Stress as a Central Biological Hub for Spaceflight Impact (2020) · cites this paper as Yin et al., 2007
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“PDGF2-alpha levels in urine are primarily related to cyclooxygenase-independent synthesis and oxidative stress (Yin et al., 2007).”
From Comprehensive Multi-omics Analysis Reveals Mitochondrial Stress as a Central Biological Hub for Spaceflight Impact (2020) · cites this paper as Yin et al., 2007
The cited source says what the claim attributes to it.
In the citing paper
“Increased prostaglandin F2 alpha levels in urine are associated with oxidative stress and cyclooxygenase independent synthesis (Yin et al., 2007).”
From Comprehensive Multi-omics Analysis Reveals Mitochondrial Stress as a Central Biological Hub for Spaceflight Impact (2020) · cites this paper as Yin et al., 2007
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Epstein, F. H., Steinberg, D., Parthasarathy, S., Carew, T. E., Khoo, J. C., & Witztum, J. L. (1989) · New England Journal of Medicine · doi:10.1056/nejm198904063201407 · Cited by 6,427
Prostaglandins and Leukotrienes: Advances in Eicosanoid Biology
Funk, C. D. (2001) · Science · doi:10.1126/science.294.5548.1871 · Cited by 3,817
Book ReviewAmbulatory Pediatric Care
Steinberg, J. B. (1989) · New England Journal of Medicine · doi:10.1056/nejm198901053200122 · Cited by 2,108
Morrow, J. D., Hill, K. E., Burk, R. F., Nammour, T. M., Badr, K. F., & Roberts, L. J. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.23.9383 · Cited by 1,899
Self-citationMorrow, J. D., Frei, B., Longmire, A. W., Gaziano, J. M., Lynch, S. M., Shyr, Y., Strauss, W. E., Oates, J. A., & Roberts, L. J. (1995) · New England Journal of Medicine · doi:10.1056/nejm199505043321804 · Cited by 1,339
Self-citationGrosser, T. (2005) · Journal of Clinical Investigation · doi:10.1172/jci27291 · Cited by 1,027
The oxidative modification hypothesis of atherogenesis: an overview
Chisolm, G. M., & Steinberg, D. (2000) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(00)00344-0 · Cited by 746
Non-cyclooxygenase-derived prostanoids (F2-isoprostanes) are formed in situ on phospholipids.
Morrow, J. D., Awad, J. A., Boss, H. J., Blair, I. A., & Roberts, L. J. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.22.10721 · Cited by 735
Self-citationKadiiska, M. B., Gladen, B. C., Baird, D. D., Germolec, D., Graham, L. B., Parker, C. E., Nyska, A., Wachsman, J. T., Ames, B. N., Basu, S., et al. (2005) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2004.09.017 · Cited by 697
Self-citationCyclooxygenase inhibitors – current status and future prospects
Dannhardt, G., & Kiefer, W. (2001) · European Journal of Medicinal Chemistry · doi:10.1016/s0223-5234(01)01197-7 · Cited by 657
Cited by
Ayala, A., Muñoz, M. F., & Argüelles, S. (2014) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2014/360438 · Cited by 6,349
“In our lab we have made extensive use of membrane-soluble CH as a model compound for lipid hydroperoxides (LOOH), which are formed in the process of lipid peroxidation during oxidative stress.”
MethodFree Radical Lipid Peroxidation: Mechanisms and Analysis
Yin, H., Xu, L., & Porter, N. A. (2011) · Chemical Reviews · doi:10.1021/cr200084z · Cited by 1,937
Self-citationDyall, S. C., Balas, L., Bazan, N. G., Brenna, J. T., Chiang, N., da Costa Souza, F., Dalli, J., Durand, T., Galano, J.-M., Lein, P. J., et al. (2022) · Progress in Lipid Research · doi:10.1016/j.plipres.2022.101165 · Cited by 660
“A perfect match with PGF2α is also produced via this mechanism (albeit racemic), and Morrow and co-workers highlighted the issues with PGF2α quantification in urine [220].”
Backgroundda Silveira, W. A., Fazelinia, H., Rosenthal, S. B., Laiakis, E. C., Kim, M. S., Meydan, C., Kidane, Y., Rathi, K. S., Smith, S. M., Stear, B., et al. (2020) · Cell · doi:10.1016/j.cell.2020.11.002 · Cited by 402
“PDGF2-alpha levels in urine are primarily related to cyclooxygenase-independent synthesis and oxidative stress (Yin et al., 2007).”
Human Biochemistry of the Isoprostane Pathway
Milne, G. L., Yin, H., & Morrow, J. D. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.r700047200 · Cited by 208
Self-citationJahn, U., Galano, J., & Durand, T. (2008) · Angewandte Chemie International Edition · doi:10.1002/anie.200705122 · Cited by 205
Advances in methods for the determination of biologically relevant lipid peroxidation products
Spickett, C. M., Wiswedel, I., Siems, W., Zarkovic, K., & Zarkovic, N. (2010) · Free Radical Research · doi:10.3109/10715762.2010.498476 · Cited by 154
Ferroptosis and cardiovascular disease: role of free radical-induced lipid peroxidation
Chen, X., Li, X., Xu, X., Li, L., Liang, N., Zhang, L., Lv, J., Wu, Y., & Yin, H. (2021) · Free Radical Research · doi:10.1080/10715762.2021.1876856 · Cited by 154
“tography may help to dissect the role of enzymatic and non-enzymatic activity of LOX in this process [97,98].”
BackgroundSelf-citationPorter, N. A. (2013) · The Journal of Organic Chemistry · doi:10.1021/jo4001433 · Cited by 120
Self-citationProstaglandins and bone metabolism
Choudhary, S., & Pilbeam, C. C. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-814841-9.00051-8 · Cited by 118
Liu, W., Morrow, J. D., & Yin, H. (2009) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2009.07.028 · Cited by 109
“However, caution should be exercised regarding the enzymatic origin of this peak; our studies show that the majority of this peak in human urine is actually derived from the free radical pathway [38].”
Self-citationRoberts, L. J., & Milne, G. L. (2008) · Journal of Lipid Research · doi:10.1194/jlr.r800037-jlr200 · Cited by 130
“In this regard, however, we have reported that PGs can be formed via the IsoP pathway as smaller amounts of endoperoxides containing trans side chains are generated in vitro and in vivo by this mechanism (10).”
BackgroundCipollone, F., Cicolini, G., & Bucci, M. (2008) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2008.01.002 · Cited by 127
Cardiolipin, Perhydroxyl Radicals, and Lipid Peroxidation in Mitochondrial Dysfunctions and Aging
Panov, A. V., & Dikalov, S. (2020) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2020/1323028 · Cited by 116
Higashi, N., Mita, H., Ono, E., Fukutomi, Y., Yamaguchi, H., 梶原, 景., 谷本, 英., Sekiya, K., Akiyama, K., & Taniguchi, M. (2010) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2009.12.977 · Cited by 93
Daughton, C. G. (2012) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2012.02.038 · Cited by 99
“This prostaglandin and its enantiomer are therefore also measures of freeradical induced oxidative stress— as opposed tomarkers of COX activity (Yin et al., 2007).”
BackgroundLee, J. C., Huang, S. H., Jenner, A. M., & Halliwell, B. B. (2007) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2007.12.026 · Cited by 87
Lu, J., Chen, B., Chen, T., Guo, S., Xue, X., Chen, Q., Zhao, M., Xia, L., Zhu, Z., Zheng, L., et al. (2017) · Redox Biology · doi:10.1016/j.redox.2017.04.032 · Cited by 90
Self-citationNavarro, S. L., White, E., Kantor, E. D., Zhang, Y., Rho, J.-H., Song, X., Milne, G. L., Lampe, P. D., & Lampe, J. W. (2015) · PLoS ONE · doi:10.1371/journal.pone.0117534 · Cited by 82
“In addition, we recently observed G&C use to be associated with 28–36% lower CRP concentrations, [37] and 40–47% lower oxidative stress, as measured by urinary prostaglandin F2α (PGF2α) [38] among a sub-set of 220 individuals in the VITAL cohort [15].”
BackgroundHoang, H. D., PRASAIN, J. K., Dorand, R. D., & Miller, M. A. (2013) · PLoS Genetics · doi:10.1371/journal.pgen.1003271 · Cited by 74
“The enantiomeric form of PGF2/, which is not formed by cyclooxygenase and cannot be distinguished from PGF2/ using standard LC-MS/MS or immunoassays, is the major F2 class prostaglandin in human urine [46] and C.”
BackgroundMethodStress ossidativo nei pazienti con diagnosi di sindrome delle apnee ostruttive notturne
Passàli, D., Corallo, G., Yaremchuk, S., Longini, M., Proietti, F., Passàli, G. C., & Bellussi, L. M. (2015) · Acta Otorhinolaryngologica Italica · doi:10.14639/0392-100x-895 · Cited by 82
Taylor, A. W., Bruno, R. S., & Traber, M. G. (2008) · Lipids · doi:10.1007/s11745-008-3222-1 · Cited by 66
“Although PGF2a is the largest of the 15-series peaks in our samples, it is likely a mixture of PGF2a and ent-PGF2a that we cannot resolve, based on the findings by Yin et al. [ 14 ], who used a chiral column and showed that the major portion of PGF2a in human urine is the enantiomer (ent) form of PGF2a.”
Lu, Y., Tian, H., & Hong, S. (2010) · Journal of Lipid Research · doi:10.1194/jlr.m000059 · Cited by 66
Liu, W., Yin, H., Ogawa, Y., Yoshida, Y., Niki, E., & Porter, N. A. (2010) · Chemical Research in Toxicology · doi:10.1021/tx1000943 · Cited by 62
Self-citationO'Brien, J. W., Choi, P. M., Li, J., Thai, P. K., Jiang, G., Tscharke, B. J., Mueller, J. F., & Thomas, K. V. (2019) · Water Research · doi:10.1016/j.watres.2019.115068 · Cited by 59
Moving forward with isoprostanes, neuroprostanes and phytoprostanes: where are we now?
Ahmed, O., Galano, J., Pavlíčková, T., Revol-Cavalier, J., Vigor, C., Lee, J. C., Oger, C., & Durand, T. (2020) · Essays in Biochemistry · doi:10.1042/ebc20190096 · Cited by 64
Kuiper, H. C., Miranda, C. L., Sowell, J. D., & Stevens, J. F. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m802797200 · Cited by 59
Yamaguchi, H., Higashi, N., Mita, H., Ono, E., Komase, Y., Nakagawa, T., Miyazawa, T., Akiyama, K., & Taniguchi, M. (2011) · Clinical & Experimental Allergy · doi:10.1111/j.1365-2222.2011.03839.x · Cited by 49
Enantiomeric Separation of Hydroxy and Hydroperoxy Eicosanoids by Chiral Column Chromatography
Schneider, C. G., Yu, Z., Boeglin, W. E., Zheng, Y.-X., & BRASH, A. R. (2007) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(07)33008-5 · Cited by 50
Recent development on liquid chromatography-mass spectrometry analysis of oxidized lipids
Li, L., Zhong, S., Shen, X., Li, Q., Xu, W., Tao, Y., & Yin, H. (2019) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2019.06.006 · Cited by 47
Self-citationBalgoma, D., Larsson, J., Rokach, J., Lawson, J. A., Daham, K., Dahlén, B., Dahlén, S., & Wheelock, C. E. (2013) · Analytical Chemistry · doi:10.1021/ac401461b · Cited by 47
Effects of celecoxib on major prostaglandins in asthma: Prostanoid biosynthesis in asthma
Daham, K., Song, W., Lawson, J. A., Kupczyk, M., Gülich, A., Dahlén, S., FitzGerald, G. A., & Dahlén, B. (2010) · Clinical & Experimental Allergy · doi:10.1111/j.1365-2222.2010.03617.x · Cited by 46
Higashi, N., Taniguchi, M., Mita, H., Yamaguchi, H., Ono, E., & Akiyama, K. (2012) · Allergology International · doi:10.2332/allergolint.11-ra-0403 · Cited by 42
Briskey, D. R., Wilson, G., Fassett, R. G., & Coombes, J. S. (2013) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/j.jpba.2013.11.028 · Cited by 38
Yin, H. (2008) · BioFactors · doi:10.1002/biof.5520340203 · Cited by 38
“reported that the F2-IsoP regioisomer and diastereomer distribution was drastically different in rat liver tissue after treatment of carbon tetrachloride and human urine [91].”
BackgroundSelf-citationChiba, T., Thomas, C. P., Calcutt, M. W., Boeglin, W. E., O’Donnell, V. B., & BRASH, A. R. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.711267 · Cited by 38
“4) (36, 37).”
Maternal Oxidative Stress Biomarkers in Pregnancy and Child Growth from Birth to Age 6
Arogbokun, O., Rosen, E. M., Keil, A. P., Milne, G. L., Barrett, E. S., Nguyen, R. H. N., Bush, N. R., Swan, S. H., Sathyanarayana, S., & Ferguson, K. K. (2021) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgab018 · Cited by 36
Zabala, V., Tong, M., Yu, R., Ramirez, T., Yalcin, E. B., Balbo, S., Silbermann, E., Deochand, C., Nuñez, K. M., Hecht, S. S., et al. (2015) · Alcohol and Alcoholism · doi:10.1093/alcalc/agu083 · Cited by 36
“oxygenase and therefore marks lipid peroxidation (Morrow et al., 1992, 1994; Sodergren et al., 2000; Yin et al., 2007).”
BackgroundHardy, K. D., Cox, B. E., Milne, G. L., Yin, H., & Roberts, I. L. J. (2010) · Journal of Lipid Research · doi:10.1194/jlr.m010264 · Cited by 33
Self-citationIanni, F., Saluti, G., Galarini, R., Fiorito, S., Sardella, R., & Natalini, B. (2019) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2019.04.038 · Cited by 33
ω-Alkynyl Lipid Surrogates for Polyunsaturated Fatty Acids: Free Radical and Enzymatic Oxidations
Beavers, W. N., Serwa, R. A., Shimozu, Y., Tallman, K. A., Vaught, M., Dalvie, E. D., Marnett, L. J., & Porter, N. A. (2014) · Journal of the American Chemical Society · doi:10.1021/ja506038v · Cited by 33
Self-citationSun, Q., Oltra, E., Dijck-Brouwer, J., Chillon, T. S., Seemann, P., Asaad, S., Demircan, K., Espejo, J., Sánchez-Fito, T., Martín‐Martínez, E., et al. (2023) · Redox Biology · doi:10.1016/j.redox.2023.102796 · Cited by 32
“They reflect radical-catalyzed oxidation of arachidonic acid independent of enzymatic cyclooxygenase activity [42].”
BackgroundPerhydroxyl Radical (HO2•) as Inducer of the Isoprostane Lipid Peroxidation in Mitochondria
Panov, A. V. (2018) · Molecular Biology · doi:10.1134/s0026893318020097 · Cited by 33
“Although in some cases smaller amounts of PGs containing trans side chains can be formed via the IsoP pathway both in vitro and in vivo [28], however, PGs derived via the IsoP pathway are generated as a racemic mixture, whereas those formed by COX are enantiomerically pure [29].”
BackgroundJahn, U., Galano, J., & Durand, T. (2008) · Angewandte Chemie · doi:10.1002/ange.200705122 · Cited by 24
Lipid peroxidation products as potential bioindicators of Lyme arthritis
Łuczaj, W., Moniuszko-Malinowska, A. M., Rusak, M., Pancewicz, S. A., Zajkowska, J. M., & Skrzydlewska, E. (2010) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-010-1102-0 · Cited by 23
“It was proven that the majority of 8-isoprostanes present in the human urine is derived from the free radical auto-oxidation of arachidonic acid rather than via COX [31], because COX inhibitors do not suppress the urinary levels of 8 isoPGF2a and the major urinary metabolites of eicosanoids such as PGE2 are significan…”
BackgroundNuñez, K. M., Kay, J., Krotow, A., Tong, M., Agarwal, A., Cadenas, E., & de la Monte, S. M. (2016) · Journal of Alzheimer s Disease · doi:10.3233/jad-150916 · Cited by 23
“Isoprostane 8-iso-PGF2 is formed by free radicalcatalyzed peroxidation of arachidonic acid and marks lipid peroxidation [49–52].”
Chemical mechanisms of lipid peroxidation
Porter, N. A. (2025) · Redox Biochemistry and Chemistry · doi:10.1016/j.rbc.2025.100054 · Cited by 21
Self-citationProstaglandin F2α Receptor Modulation Affects Eye Development in Guinea Pigs
Yang, J., Pan, M., Reinach, P. S., Chen, R., Yu, L., Zhou, F., Zhang, S., Qu, J., & Zhou, X. (2018) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/bcpt.13017 · Cited by 18
Panov, A. V. (2018) · Molecular Biology · doi:10.7868/s0026898418030011 · Cited by 23
Specialty Supplement Use and Biologic Measures of Oxidative Stress and DNA Damage
Kantor, E. D., Ulrich, C. M., Owen, R. W., Schmezer, P., Neuhouser, M. L., Lampe, J. W., Peters, U., Shen, D. D., Vaughan, T. L., & White, E. (2013) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-13-0470 · Cited by 16
“Recentwork has shown that urinary PGF2a is formed by a similar COX-independent isoprostane pathway, and can be used as a measure of oxidative stress (42).”
BackgroundCritical Methods in Free Radical Biology & Medicine
Forman, H. J. (2009) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2009.09.013 · Cited by 15
Radix Saposhnikoviae enhancing Huangqi Chifeng Decoction improves lipid metabolism in AS mice
Fu, J., Liang, Y., Yu, D., Wang, Y., Lü, F., & Liu, S. (2023) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2023.117479 · Cited by 14
Depressed prostaglandins and leukotrienes in veterans with Gulf War illness
Golomb, B. A., Koslik, H. J., Christians, U., Ritchie, J. B., Wilson, P. V., Elkins, N. D., Klawitter, J., Klawitter, J., Smith, D. M., & Repine, J. E. (2019) · Journal of Environmental Science and Health Part B · doi:10.1080/03601234.2019.1596001 · Cited by 12
“Pgf2a can be substantially generated from peroxidation of arachidonic acid.([49]) One hypothesis is that arachidonic acid – and others of its products – may be depressed in GWI.”
BackgroundAl‐Matubsi, H. Y., Salim, M. D., El-Sharaky, A. S., Kamel, M. A. E.-N., Oriquat, G. A., Helmy, M. H., El-Bassiouni, E. A., & Shourbaji, M. A. (2010) · Diabetes & Metabolism · doi:10.1016/j.diabet.2009.06.009 · Cited by 14
Are prostatitis symptoms associated with an isoprostane-mediated vicious circle?
Türk, S., & Kullisaar, T. (2011) · Medical Hypotheses · doi:10.1016/j.mehy.2011.07.050 · Cited by 11
“8-isoprostanes [12] and prostaglandin F2a (PGF2a) [34].”
Passàli, D., Corallo, G., Petti, A., Longini, M., Passàli, F. M., Buonocore, G., & Bellussi, L. M. (2016) · Acta Otorhinolaryngologica Italica · doi:10.14639/0392-100x-1361 · Cited by 11
Chapter 29 – Oxidative Stress and Excitotoxicity: Antioxidants from Nutraceuticals
Milatović, D., Zaja‐Milatovic, S., & Gupta, R. C. (2016) · Academic Press eBooks · Cited by 11
Lu, Y., Tian, H., Peng, H., Wang, Q., Bunnell, B. A., Bazan, N. G., & Hong, S. (2024) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2024.1380059 · Cited by 10
Szöri, M., Csizmadia, I. G., & Viskolcz, B. (2008) · Journal of Chemical Theory and Computation · doi:10.1021/ct800127a · Cited by 10
Biomarkers of oxidative/nitrosative stress and neurotoxicity
Milatović, D., Zaja‐Milatovic, S., & Gupta, R. C. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-404630-6.00052-x · Cited by 10
Al‐Matubsi, H. Y., Oriquat, G. A., Abu‐Samak, M., Al-Hanbali, O. A., & Salim, M. D. (2016) · Journal of Diabetes Research · doi:10.1155/2016/9354937 · Cited by 9
Helbig, D., Wagner, A., Glei, M., Basu, S., Schubert, R., & Jahreis, G. (2009) · British Journal Of Nutrition · doi:10.1017/s0007114509220812 · Cited by 8
Oxidative Stress and Excitotoxicity
Milatović, D., Zaja‐Milatovic, S., & Gupta, R. C. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-802147-7.00029-2 · Cited by 8
Isoprostanoids, Isofuranoids and Isoketals – From Synthesis to Lipidomics
Vigor, C., Balas, L., Guy, A., Bultel‐Poncé, V., Réversat, G., Galano, J., Durand, T., & Oger, C. (2022) · European Journal of Organic Chemistry · doi:10.1002/ejoc.202101523 · Cited by 8
Prostaglandins and Bone Metabolism
Pilbeam, C. C., Choudhary, S., Blackwell, K. A., & Raisz, L. G. (2008) · Elsevier eBooks · doi:10.1016/b978-0-12-373884-4.00072-0 · Cited by 17
Tiwary, E., Hu, M., Miller, M. A., & PRASAIN, J. K. (2019) · Scientific Reports · doi:10.1038/s41598-019-48062-y · Cited by 7
The profile of lipid metabolites in urine of marmoset wasting syndrome
Yamazaki, A., Nakamura, T., Miyabe‐Nishiwaki, T., Hirata, A., Inoue, R., Kobayashi, K., Miyazaki, Y., Hamasaki, Y., Ishigami, A., Nagata, N., et al. (2020) · PLoS ONE · doi:10.1371/journal.pone.0234634 · Cited by 6
Smrček, J., Hájek, M., Hodek, O., Čížek, K., Pohl, R., Jahn, E., Galano, J., Oger, C., Durand, T., Cvačka, J., et al. (2021) · Chemistry - A European Journal · doi:10.1002/chem.202100872 · Cited by 5
Lipidomic approaches to measuring isoprostanes and other markers of oxidative stress
Davies, S. S. (2008) · European Journal of Lipid Science and Technology · doi:10.1002/ejlt.200800132 · Cited by 8
Eick, S. M., Celia-Sanchez, M. L., Woodruff, T. J., Goin, D. E., Padula, A. M., Cushing, L. J., Ortlund, K., DeMicco, E., Milne, G. L., & Morello-Frosch, R. A. (2025) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2025.03.036 · Cited by 4
Antioxidants in Prevention and Treatment of Diseases and Toxicity
Milatović, D., & Gupta, R. C. (2019) · Springer eBooks · doi:10.1007/978-3-030-04624-8_14 · Cited by 6
Lipid Peroxidation and Nitration
Davies, S. S., & Guo, L. (2013) · Wiley eBooks · doi:10.1002/9781118355886.ch2 · Cited by 4
Detection of F 2 -isoprostanes and F 4 -neuroprostanes in Clinical Studies
Yen, H. (2010) · doi:10.30046/jbls.201003.0001 · Cited by 6
“On the other hand, as mentioned above, the peak of PGF2α (peak b) might contain ent-PGF2α especially in urine [15].”
BackgroundTsikas, D. (2017) · Journal of Controversies in Biomedical Research · doi:10.15586/jcbmr.2017.20 · Cited by 2
“Yet, there is also solid evidence that PGF2α is an abundant non-enzymatic oxidation product of arachidonic acid (4).”
BackgroundBiomarkers of Oxidative/Nitrosative Stress and Neurotoxicity
Milatović, D., Zaja‐Milatovic, S., & Gupta, R. C. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-814655-2.00057-8 · Cited by 2
Oxidative stress and excitotoxicity: antioxidants from nutraceuticals
Zaja‐Milatovic, S., & Gupta, R. C. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-821038-3.00031-8 · Cited by 3
The Isoprostanes: Accurate Markers and Potent Mediators of Oxidant Injury in Vivo
Brooks, J. D., Cox, B. E., Hardy, K. D., Sanchez, S. C., Touriño, S., Koestner, T. H., Howard, J. R. H., & Milne, G. L. (2010) · Wiley eBooks · doi:10.1002/9780813814438.ch5
O’Donnell, V. B. (2009) · Wiley eBooks · doi:10.1002/9783527627585.ch10
Total syntheses of neuroprostanes
Pavlíčková, T. (2020) · theses.fr (ABES) · doi:10.70675/6d1c6331z67b3z4833z84a2z2dd8369674f2
Metadata
- Authors
- Yin, H., Gao, L., Tai, H.-H., Murphey, L. J., Porter, N. A., & Morrow, J. D.
- Affiliations
- Vanderbilt University (US)
- University of Kentucky (US)
- Corresponding author
- Morrow, Jason D.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2007-01
- Volume
- 282
- Issue
- 1
- Pages
- 329-336
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2083913738
- Cited by
- 82
- References
- 39
- Citations by year
- 2025: 2 · 2024: 1 · 2023: 2 · 2022: 2 · 2021: 4 · 2020: 5 · 2019: 8 · 2018: 3 · 2017: 2 · 2016: 7 · 2015: 4 · 2014: 3 · 2013: 6 · 2012: 2
- FWCI
- 3.76
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- creativecommons.org/licenses/by/4.0/ (vor, 5012 d)
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (ES00267, ES000267, GM 15431, CA 77839)
- National Heart, Lung, and Blood Institute (HL-17921)
- National Cancer Institute (CA77839, P01CA077839)
- National Institute of General Medical Sciences (GM 15431)
- National Institute of Diabetes and Digestive and Kidney Diseases (DK 48831, R01DK048831)
- National Institute of Environmental Health Sciences (P30ES000267, ES00267)
- National Center for Research Resources (RR00095)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Inflammatory mediators and NSAID effects
- Health Sciences › Medicine › Biochemistry (medical) › Antioxidant Activity and Oxidative Stress
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Eicosanoids and Hypertension Pharmacology
- Keywords
- isoprostanes, arachidonic acid oxidation, oxidative stress biomarkers, cigarette smoking, hypercholesterolemia, nonsteroidal anti-inflammatory drugs, enantiomeric ratio
- MeSH terms
- Animals, Female, Free Radicals, Humans, Lipids, Liver, Male, Oxygen, Phospholipids, Prostaglandin-Endoperoxide Synthases, Smoking, Dinoprost, Oxidative Stress, Isoprostanes, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.